Education
About Us
Working with TipRanks
Follow Us
New Portfolio - New Portfolio
Richard
New PortfolioIndividual Investor
Ranked #518,907 out of 852,708 TipRanks' Investors
Success Rate
829 out of 2115
profitable transactions
profitable transactions
Average Return
2.98%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 1.71%
6-Month Return▲ 44.75%
12-Month Return▲ 38.27%
YTD Return▲ 2.79%
Total Return▲ 52.43%
Best Trade
Bio
Performance
12.88%0-12.88%
▲ 7.60%
▲ 2.30%
▲ 6.13%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 12.40%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 12.88%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 4.62%
Oct 2025
▼ 3.58%
▲ 0.19%
▲ 7.20%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 0.58%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 5.05%
Jan 2026
▼ 5.01%
▼ 2.07%
▼ 2.15%
Feb 2026
▲ 7.60%▲ 2.30%▲ 6.13%
▲ 2.76%▲ 2.05%▲ 12.40%
▲ 12.88%▲ 3.56%▲ 12.88%
▲ 10.96%▲ 2.38%▲ 4.62%
▼ 3.58%▲ 0.19%▲ 7.20%
▼ 0.10%▲ 0.08%▲ 0.58%
▲ 4.06%▲ 1.47%▲ 5.05%
▼ 5.01%▼ 2.07%▼ 2.15%
Recent Activity
ProShares UltraShort QQQ
8.6%
▲ 0.68%
19
Buy
Feb 05, 2026
Wesdome Gold Mines
2.64%
0.00%
1
Open
Feb 05, 2026
Harrow Health
2.64%
▲ 58.82%
61
Open
Feb 02, 2026
i-80 Gold Corp
1.95%
▼ 3.46%
20
Open
Feb 02, 2026
Fractyl Health, Inc.
0.57%
▼ 35.84%
3
Open
Feb 02, 2026
Invesco DB Base Metals Fund
―
▼ 2.54%
5
Close
Jan 30, 2026
NextNav
3.12%
▲ 1.26%
39
Buy
Jan 30, 2026
ProShares UltraShort S&P500
36.02%
▲ 2.12%
26
Buy
Jan 29, 2026
ProShares UltraShort Russell2000
6.81%
▲ 0.50%
31
Open
Jan 28, 2026
Cardiff Oncology
―
▼ 7.47%
10
Close
Jan 27, 2026
Tradr 1X Short Innovation Daily ETF
―
▲ 2.27%
32
Close
Jan 27, 2026
ProShares UltraPro Short Russell2000
―
▲ 1.25%
6
Close
Jan 27, 2026
ProShares UltraShort Silver
―
▼ 8.06%
2
Close
Jan 27, 2026
Acumen Pharmaceuticals
1.29%
▼ 22.92%
14
Buy
Jan 26, 2026
Direxion Daily S&P Biotech Bear 3X Shares
―
▼ 2.60%
8
Close
Jan 24, 2026
RegenXBio
―
▲ 1.59%
4
Close
Jan 23, 2026
Infinity Natural Resources, Inc. Class A
3.74%
▲ 16.99%
1
Open
Jan 20, 2026
Artiva Biotherapeutics, Inc.
1.77%
▼ 24.11%
25
Sell
Jan 13, 2026
IDEAYA Biosciences
―
▼ 4.42%
15
Close
Jan 13, 2026
Structure Therapeutics, Inc. Sponsored ADR
―
▲ 191.00%
5
Close
Jan 13, 2026